Health ❯ Healthcare ❯ Diabetes ❯ Type 2 Diabetes

GLP-1 Receptor Agonists

Cue-Driven Eaters Lose More Weight on GLP-1 Drugs, Japanese Study Finds

Researchers say brief screening for eating cues may help tailor expectations for GLP-1 therapy.

Bariatric Surgery Outperforms GLP-1 Medicines Over 10 Years for Patients With Diabetes and Obesity

Eli Lilly to Raise UK Mounjaro Prices by Up to 170% in September

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control